448 Age-related amyloid β protein accumulation induces cellular death and macrophage activation

1996 ◽  
Vol 17 (4) ◽  
pp. S111-S112
Author(s):  
M. Shoji ◽  
T. Kawarabayashi ◽  
Y. Igeta ◽  
Y. Tomidokoro ◽  
K. Ishiguro ◽  
...  
2002 ◽  
Vol 4 (1) ◽  
pp. 31-37 ◽  
Author(s):  
Roberta Borghi ◽  
Luca Pellegrini ◽  
Emanuela Lacaná ◽  
Alberto Diaspro ◽  
Maria Adelaide Pronzato ◽  
...  

2000 ◽  
Vol 157 (6) ◽  
pp. 2093-2099 ◽  
Author(s):  
Maho Morishima-Kawashima ◽  
Noriko Oshima ◽  
Hiromitsu Ogata ◽  
Haruyasu Yamaguchi ◽  
Masahiro Yoshimura ◽  
...  

2006 ◽  
Vol 84 (6) ◽  
pp. 1343-1349 ◽  
Author(s):  
Makoto Yanagisawa ◽  
Toshio Ariga ◽  
Robert K. Yu

Stem Cells ◽  
2019 ◽  
Vol 37 (11) ◽  
pp. 1467-1480 ◽  
Author(s):  
Domenica Donatella Li Puma ◽  
Roberto Piacentini ◽  
Lucia Leone ◽  
Katia Gironi ◽  
Maria Elena Marcocci ◽  
...  

2016 ◽  
Vol 52 (4) ◽  
pp. 1209-1214 ◽  
Author(s):  
Anna Pliássova ◽  
Paula M. Canas ◽  
Ana Carolina Xavier ◽  
Beatriz S. da Silva ◽  
Rodrigo A. Cunha ◽  
...  

2021 ◽  
Vol 15 ◽  
Author(s):  
Zenghui Wei ◽  
Jagadish Koya ◽  
Sandra E. Reznik

Alzheimer disease (AD) is a chronic neurodegenerative disease that accounts for 60–70% of dementia and is the sixth leading cause of death in the United States. The pathogenesis of this debilitating disorder is still not completely understood. New insights into the pathogenesis of AD are needed in order to develop novel pharmacologic approaches. In recent years, numerous studies have shown that insulin resistance plays a significant role in the development of AD. Over 80% of patients with AD have type II diabetes (T2DM) or abnormal serum glucose, suggesting that the pathogenic mechanisms of insulin resistance and AD likely overlap. Insulin resistance increases neuroinflammation, which promotes both amyloid β-protein deposition and aberrant tau phosphorylation. By increasing production of reactive oxygen species, insulin resistance triggers amyloid β-protein accumulation. Oxidative stress associated with insulin resistance also dysregulates glycogen synthase kinase 3-β (GSK-3β), which leads to increased tau phosphorylation. Both insulin and amyloid β-protein are metabolized by insulin degrading enzyme (IDE). Defects in this enzyme are the basis for a strong association between T2DM and AD. This review highlights multiple pathogenic mechanisms induced by insulin resistance that are implicated in AD. Several pharmacologic approaches to AD associated with insulin resistance are presented.


Sign in / Sign up

Export Citation Format

Share Document